OVID

Ovid Therapeutics Inc. · Healthcare · Market cap $525.4M

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$29K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Latest filing

Jul 8, 2026

Rona Jeffrey A

Ovid Therapeutics Inc. (OVID) has 9 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 8, 2026.

Inside the rolling window, 2 insiders at Ovid Therapeutics Inc. reported no open-market purchases and 2 open-market sales totaling $29K. The most recent open-market filing is a sale of 8,541 shares by CBFO Rona Jeffrey A, dated Feb 23, 2026, worth $12K.

  • Industry:Biotechnology
  • CEO:Margaret Alexander
  • Employees:23
  • HQ:New York City, NY, US
  • IPO:2017-05-05
Source
Rona Jeffrey AFirst filing
Sale$12KMar 2SEC ↗
ALEXANDER MARGARET A.First filing
Sale$17KMar 2SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does OVID have?

Ovid Therapeutics Inc. (OVID) has 9 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jul 8, 2026.

When was the most recent SEC Form 4 filing for OVID?

The most recent Form 4 filing for OVID on Tracefour is dated Jul 8, 2026.

What is the net insider flow at OVID over the last 6 months?

Over the trailing 180 days, insiders at OVID have net sold $29K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at OVID in the current window?

Inside the rolling window, insiders at OVID bought $0 and sold $29K based on SEC Form 4 filings.

Can I get alerts for OVID insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Ovid Therapeutics Inc. (OVID). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Ovid Therapeutics Inc. is in the Healthcare sector.